Bank of New York Mellon’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-282,981
| Closed | -$574K | – | 4399 |
|
|
2016
Q1 | $574K | Sell |
282,981
-49,579
| -15% | -$88.4K | ﹤0.01% | 3372 |
|
|
2015
Q4 | $825K | Sell |
332,560
-6,714
| -2% | -$19.9K | ﹤0.01% | 3288 |
|
|
2015
Q3 | $882K | Sell |
339,274
-69,507
| -17% | -$181K | ﹤0.01% | 3264 |
|
|
2015
Q2 | $1.28M | Buy |
408,781
+30,871
| +8% | +$106K | ﹤0.01% | 3197 |
|
|
2015
Q1 | $1.08M | Buy |
377,910
+8,324
| +2% | +$21.3K | ﹤0.01% | 3263 |
|
|
2014
Q4 | $953K | Buy |
369,586
+11,244
| +3% | +$49.2K | ﹤0.01% | 3339 |
|
|
2014
Q3 | $2.67M | Buy |
358,342
+10,382
| +3% | +$97K | ﹤0.01% | 2674 |
|
|
2014
Q2 | $4.1M | Buy |
347,960
+117,343
| +51% | +$1.25M | ﹤0.01% | 2433 |
|
|
2014
Q1 | $2.68M | Sell |
230,617
-7,787
| -3% | -$91.6K | ﹤0.01% | 2694 |
|
|
2013
Q4 | $2.6M | Sell |
238,404
-2,419
| -1% | -$23.8K | ﹤0.01% | 2720 |
|
|
2013
Q3 | $2.6M | Sell |
240,823
-19,025
| -7% | -$217K | ﹤0.01% | 2678 |
|
|
2013
Q2 | $3.05M | Buy |
+259,848
| New | +$2.6M | ﹤0.01% | 2508 |
|
Bank of New York Mellon's SZYM Position: Q2 2016 in Review
Bank of New York Mellon sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 282,981 shares — an estimated $574K sold.
Bank of New York Mellon first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $4.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.
- Bank of New York Mellon reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
- Bank of New York Mellon sold 282,981 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $574K.
- Bank of New York Mellon first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
- Bank of New York Mellon's SOLAZYME INC COM STK (DE) position peaked at $4.1M in Q2 2014.
- 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.
Based on Bank of New York Mellon's 13F filing for Q2 2016, filed 1 Aug 2016.